<ѻý class="article_title">
Invasive Pneumococcal Disease in Alaskan Adults Experiencing Homelessness
ѻý>
Low uptake of pneumococcal conjugate vaccines among adults contributes to an increase in invasive pneumococcal disease, especially in those experiencing homelessness, say the Alaska-based authors of a new study.
<ѻý class="article_title">
When Children Get the Pneumococcal Vaccine, Adults Benefit, Too
ѻý>
New information from Germany confirms that vaccinating children for pneumococcal disease has a protective effect on adults. But don’t count on the kids—adults need their own vaccinations, as well.
<ѻý class="article_title">
Pneumococcal Carriage in the COVID-19 Era
ѻý>
New research found that despite COVID-19-era precautions—including masking and social distancing—rates of pneumococcal carriage among older adults were similar to those reported in this population before the pandemic.
<ѻý class="article_title">
Determining the Best Time to Vaccinate Against Invasive Pneumococcal Disease
ѻý>
In a study of 4 countries, an international team of experts set out recently to determine the optimal age for older adults to receive a single-dose pneumococcal vaccine.
<ѻý class="article_title">
Vaccination Against IPD: A One-Two Protective Punch for Patients with Sickle Cell Disease
ѻý>
Invasive pneumococcal disease is a deadly complication of sickle cell disease (SCD). A new report, however, suggests that immunization with PCV13 plus PPSV23 produces a better humoral immune response than PPSV23 alone in adults with SCD.
<ѻý class="article_title">
PCV13 and Pneumonia Hospitalization in Older Adults
ѻý>
A recent study explored whether 13-valent pneumococcal conjugate vaccine (PCV13) reduces pneumonia hospitalizations among older adults with a high prevalence of underlying conditions.
<ѻý class="article_title">
Can This One Deadly Disease (Pneumonia) Trigger Another (MI)?
ѻý>
Do patients who get pneumonia increase their risk of a heart attack? And if so, by how much? Do only older people need to be worried about this? These questions were at the focus of a case series study that used data spanning a 16-year period.
<ѻý class="article_title">
Invasive Pneumococcal Disease: Which Workplace Exposures Raise the Risk?
ѻý>
That was the question asked by Swedish investigators who examined the effect of occupational exposures—including their nature and work location—on the risk of transmission of invasive pneumococcal disease.
<ѻý class="article_title">
Do Adults Benefit When Kids Get Pneumococcal Conjugate Vaccines?
ѻý>
The answer appears to be "yes." A sharp decrease in rates of pneumococcal pneumonia caused by pneumococcal conjugate vaccine serotypes was observed in men and women, according to these recent findings from a Japanese study.
<ѻý class="article_title">
PCV13 Is Shifting Trends in Invasive Pneumococcal Disease
ѻý>
With data from patients in Olmstead County, Minnesota, researchers at Mayo Clinic recently took a close look at the efficacy of the 13-valent pneumococcal conjugate vaccine (PCV13). Here’s what they found.